Psychiatrie und Psychotherapie up2date, Table of Contents Psychiatrie und Psychotherapie up2date 2007; 1(01): 25-44DOI: 10.1055/s-2006-951882 Schizophrenien und andere psychotische Störungen Pharmakotherapie therapieresistenter schizophrener Störungen Gerhard Gründer Recommend Article Abstract Buy Article All articles of this category Full Text References Literatur Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine.. Arch Gen Psychiatry 1988; 45: 789-796 Conley RR, Kelly DL. Management of treatment resistance in schizophrenia.. Biol Psychiatry 2001; 50: 898-911 Agid O, Kapur S, Arenovich T, Zipursky RB. Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected.. Arch Gen Psychiatry 2003; 60: 1228-1235 Emsley R, Rabinowitz J, Medori R. Time course for antipsychotic treatment response in first-episode schizophrenia.. Am J Psychiatry 2006; 163: 743-745 Farde L, Nordström AL, Wiesel FA, Pauli S, Haldin C, Sedvall G. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: Relation to extrapyramidal side effects.. Arch Gen Psychiatry 1992; 49: 538-544 Baldessarini RJ, Cohen BM, Teicher MH. Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses.. Arch Gen Psychiatry 1988; 45: 79-91 Wolkin A, Barouche F, Wolf AP, Rotrosen J, Fowler JS, Shiu CY. et al. Dopamine blockade and clinical response: Evidence for two biological subgroups of schizophrenia.. Am J Psychiatry 1989; 146: 905-908 Juarez-Reyes MG, Shumway M, Battle C, Bacchetti P, Hansen MS, Hargreaves WA. Effects of stringent criteria on eligibility for clozapine among public mental health clients.. Psychiatr Serv 1995; 46: 801-806 Grech A, Os J Van , Jones PB, Lewis SW, Murray RM. Cannabis use and outcome of recent onset psychosis.. Eur Psychiatry 2005; 20: 349-353 Hiemke C, Baumann P, Laux G, Kuss H-J. Therapeutisches Drug-Monitoring in der Psychiatrie.. Psychopharmakotherapie 2005; 12: 166-182 Benkert O, Hippius H. Kompendium der Psychiatrischen Pharmakotherapie. 5. Aufl. . Heidelberg: Springer 2005 Hippius H. The history of clozapine.. Psychopharmacology 1989; 99 Suppl.: S3-5 Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine.. Arch Gen Psychiatry 1988; 45: 789-796 Moncrieff J. Clozapine vs. conventional antipsychotic drugs for treatment-resistant schizophrenia: a re-examination.. Br J Psychiatry 2003; 183: 161-166 Chakos M, Lieberman J, Hoffman E, Bradford D, Sheitman B. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.. Am J Psychiatry 2001; 158: 518-526 Volavka J, Czobor P, Sheitman B, Lindenmayer J-P, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.. Am J Psychiatry 2002; 159: 255-262 Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer JP, Potkin S. International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).. Arch Gen Psychiatry 2003; 60: 82-91 Erratum in: Arch Gen Psychiatry 2003; 60: 735 Conley RR, Tamminga CA, Bartko JJ, Richardson C, Peszke M, Lingle J, Hegerty J, Love R, Gounaris C, Zaremba S. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.. Am J Psychiatry 1998; 155: 914-920 Wirshing DA, Marshall BD, Green MF, Mintz J, Marder SR, Wirshing WC. Risperidone in treatment-refractory schizophrenia.. Am J Psychiatry 1999; 156: 1374-1379 Lewis SW, Barnes TR, Davies L, Murray RM, Dunn G, Hayhurst KP, Markwick A, Lloyd H, Jones PB. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.. Schizophr Bull 2006; 32: 715-723 McEvoy JP, Lieberman JA, Stroup TS, Davis SM, Meltzer HY, Rosenheck RA, Swartz MS, Perkins DO, Keefe RSE, Davis CE, Severe J, Hsiao JK. Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.. Am J Psychiatry 2006; 163: 600-610 Shiloh R, Zemishlany Z, Aizenberg D, Radwan M, Schwartz B, Dorfman-Etrog P, Modai I, Khaikin M, Weizman A. Sulpiride augmentation in people with schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled study.. Br J Psychiatry 1997; 171: 569-573 Josiassen RC, Joseph A, Kohegyi E, Stokes S, Dadvand M, Paing WW, Shaughnessy RA. Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial.. Am J Psychiatry 2005; 162: 130-136 Honer WG, Thornton AE, Chen EY, Chan RC, Wong JO, Bergmann A, Falkai P, Pomarol-Clotet E, McKenna PJ, Stip E, Williams R, MacEwan GW, Wasan K, Procyshyn R. Clozapine and Risperidone Enhancement (CARE) Study Group. Clozapine alone versus clozapine and risperidone with refractory schizophrenia.. N Engl J Med 2006; 354: 472-482 Siris SG, Morgan V, Fagerstrom R, Rifkin A, Cooper TB. Adjunctive imipramine in the treatment of postpsychotic depression. A controlled trial.. Arch Gen Psychiatry 1987; 44: 533-539 Kirli S, Caliskan M. A comparative study of sertraline versus imipramine in postpsychotic depressive disorder of schizophrenia.. Schizophr Res 1998; 33: 103-111 Addington D, Addington J, Patten S, Remington G, Moamai J, Labelle A, Beauclair L. Double-blind, placebo-controlled comparison of the efficacy of sertraline as treatment for a major depressive episode in patients with remitted schizophrenia.. J Clin Psychopharmacol 2002; 22: 20-25 Lane HY, Chang YC, Liu YC, Chiu CC, Tsai GE. Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study.. Arch Gen Psychiatry 2005; 62 (11): 1196-1204 Sensky T, Turkington D, Kingdon D, Scott JL, Scott J, Siddle R, O'Carroll M, Barnes TR. A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication.. Arch Gen Psychiatry 2000; 57: 165-172 Valmaggia LR, Gaag M van der , Tarrier N, Pijnenborg M, Slooff CJ. Cognitive-behavioural therapy for refractory psychotic symptoms of schizophrenia resistant to atypical antipsychotic medication. Randomised controlled trial.. Br J Psychiatry 2005; 186: 324-330 Wahlbeck K, Cheine MV, Essali A. Clozapine versus typical neuroleptic medication for schizophrenia.. The Cochrane Database of Systematic Reviews 2006; Issue 3: 0
